USD 39.81 million
Bacteriophage Market Size, Share, Growth Analysis, By Type(DsDNA Bacteriophage, SsDNA Bacteriophage, and SsRNA Bacteriophage), By Application(Animal Health, Agriculture, Aquaculture, Food Industry), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2196 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
66
|Figures:
75
Bacteriophage Market Insights
Bacteriophage Market size was valued at USD 39.81 million in 2021 and is poised to grow from USD 41.72 million in 2022 to USD 60.71 million by 2030, growing at a CAGR of 4.5% in the forecast period (2023-2030).
The global bacteriophage market is gaining traction as a promising avenue for addressing antibiotic resistance and combating bacterial infections. Bacteriophages, or phages, are naturally occurring viruses that specifically target and infect bacteria, offering a potential alternative to traditional antibiotics. The market's growth is propelled by the rising concern over antibiotic-resistant bacteria, which pose a significant global health threat. Bacteriophages have garnered attention due to their high specificity, ability to evolve with bacteria, and minimal impact on beneficial microbiota. Phage therapy, the use of bacteriophages to treat bacterial infections, has shown promising results in preclinical and clinical studies. Research and development efforts are focused on identifying and isolating phages with therapeutic potential against various bacterial strains. Regulatory approvals for phage-based therapies have been granted in some regions, further bolstering market expansion. The market's future holds potential for growth as collaborations between pharmaceutical companies, research institutions, and regulatory bodies facilitate the development and commercialization of phage-based therapies. The ability of bacteriophages to target specific bacteria, reduce the risk of resistance, and offer personalized treatment options positions them as a valuable tool in the fight against antibiotic-resistant infections. Continued research, clinical trials, and regulatory advancements are expected to drive the Bacteriophage Market's evolution, making it a critical player in the global antimicrobial landscape.
US Bacteriophage Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
DsDNA Bacteriophage
Fastest Growth
DsDNA Bacteriophage
Growth Rate
4.5% CAGR
Global Bacteriophage Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Bacteriophage Market Segmental Analysis
The globaL bacteriophage market is segmented on the basis of Type, Application, and region. By Type, the market is segmented into DsDNA Bacteriophage, SsDNA Bacteriophage, SsRNA Bacteriophage, and Others. By Application, the market is segmented into Animal Health, Agriculture, Aquaculture, Food Industry, Human Health, Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Bacteriophage Market Analysis By Type
In the bacteriophage market, among the different types of bacteriophages, the DsDNA Bacteriophage segment holds a dominant position in the market. DsDNA (Double-stranded DNA) bacteriophages are widely studied and utilized due to their versatility and effectiveness in combating bacterial infections. Their ability to infect a broad range of bacterial species and their potential for various applications, including biocontrol agents, diagnostics, and research tools, contribute to their dominant market position.
On the other hand, the fastest-growing segment is the SsRNA Bacteriophage. Single-stranded RNA (SsRNA) bacteriophages have gained significant attention for their unique properties and potential applications. Their distinct mechanisms of action and potential in targeting specific bacteria offer novel avenues for bacterial control. As research advances and more applications are explored, the SsRNA Bacteriophage segment is projected to experience rapid growth, driven by its potential in precision medicine, biotechnology, and targeted therapies against bacterial infections. The increasing understanding of RNA-based technologies and the expanding scope of personalized medicine contribute to the rapid growth of this segment in the Bacteriophage Market.
Bacteriophage Market Analysis By Application
In the Bacteriophage market, the dominant segment is likely to be Human Health. Bacteriophages, or phages, are viruses that specifically target and kill bacteria, making them a promising tool for combating bacterial infections, including antibiotic-resistant strains. The rising concern over antibiotic resistance has fueled research into alternative therapeutic options, boosting the use of bacteriophages for treating various bacterial infections in humans.
The fastest-growing segment is expected to be Agriculture. Bacteriophages are being explored as natural alternatives to chemical pesticides in agriculture. They can target harmful bacteria that cause plant diseases, offering a sustainable and environmentally friendly approach to crop protection. As the demand for safer and more sustainable agricultural practices increases, the adoption of bacteriophages in crop protection is likely to experience rapid growth, driving the Agriculture segment of the bacteriophage market.
Global Bacteriophage Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Bacteriophage Market Regional Insights
The global bacteriophage market is analyzed based on its regional presence, which includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. In the Bacteriophage Market, North America stands out as a dominant region in terms of market share. The region's advanced healthcare infrastructure, robust research and development activities, and regulatory support for phage therapy contribute to its prominent position. Bacteriophages are gaining traction as potential alternatives to antibiotics, and North America's established pharmaceutical and biotechnology industry accelerates their integration into medical practices.
On the other hand, Asia-Pacific is experiencing the fastest growth in the bacteriophage market. Factors such as a high burden of antibiotic-resistant infections, increasing awareness about phage therapy, and growing investments in healthcare infrastructure are propelling the market forward in this region. Countries like India, China, and South Korea are witnessing rapid growth due to their large population, rising healthcare expenditures, and increasing demand for novel therapeutic options.
Global Bacteriophage Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Bacteriophage Market Dynamics
Bacteriophage Market Drivers
Rise in Antibiotic Resistance:
- The increasing prevalence of antibiotic-resistant bacterial infections has driven the demand for alternative treatment options. Bacteriophages, which are viruses that target and kill specific bacteria, offer a promising avenue for combating antibiotic-resistant bacteria and superbugs. As conventional antibiotics become less effective, the bacteriophage market is propelled by the need for innovative and personalized therapeutic approaches.
Growing Focus on Personalized Medicine:
- Bacteriophages can be tailored to target specific bacterial strains, allowing for personalized treatment strategies. The trend towards personalized medicine, where treatments are customized based on an individual's genetic and microbiome profile, has led to increased interest in bacteriophage therapy. This approach holds potential for more effective and targeted treatments, thereby contributing to the growth of the bacteriophage market.
Bacteriophage Market Restraints
Regulatory Challenges:
- Bacteriophage therapy involves live viruses, which can pose regulatory challenges due to safety concerns. Ensuring the safety and efficacy of bacteriophage products requires rigorous testing and approval processes, which can be time-consuming and costly. Regulatory uncertainties and variations across different regions can hinder the market's growth and expansion.
Limited Clinical Data and Standardization:
- Despite their potential, there is a lack of comprehensive clinical data and standardized protocols for bacteriophage therapy. Variability in production methods, dosing, and administration protocols can impact treatment outcomes and hinder widespread adoption. The absence of standardized guidelines may lead to skepticism among healthcare professionals and hinder the integration of bacteriophage therapy into mainstream medical practice.
Request Free Customization of this report to help us to meet your business objectives.
Bacteriophage Market Competitive Landscape
The global bacteriophage market's competitive landscape is evolving rapidly with a growing number of biotech companies focusing on phage-based therapies and solutions. Established players like Adaptive Phage Therapeutics, Pherecydes Pharma, and Eligo Bioscience lead in research and development. Collaborations between pharmaceutical giants and smaller startups are driving innovation and product pipelines. Regulatory approvals and clinical trials are shaping the market's dynamics, creating opportunities for new entrants. Intellectual property rights and technology acquisitions also influence the landscape. As the antimicrobial resistance crisis intensifies, the Bacteriophage market is expected to witness intensified competition, consolidation, and increased investment in research and commercialization efforts.
Bacteriophage Market Top Player’s Company Profile
- Microgen (U.S.)
- Micreos (Netherlands)
- ATCC (U.S.)
- Intralytix, Inc. (U.S.)
- Adaptive Phage Therapeutics (U.S.)
- Armata pharmaceuticals Inc. (U.S.)
- LOCUS BIOSCIENCES, INC. (U.S.)
- Delmont Laboratories, Inc. (U.S.)
- Nextbiotics (U.S.)
- Pherecydes Pharma (France)
- iNtODEWORLD. Inc. (U.S.)
- Enbiotix (U.S.)
- Fixed-Phage Limited (U.K.)
- Cytophage Technologies Inc. (Canada)
- Eliava Bio Preparations LTD (Georgia)
- Phagelux, Inc. (China)
- InnoPhage, Ltd (Hong Kong)
- TechnoPhage (Portugal)
- Eligo Bioscience SA (France)
- BiomX Ltd. (Israel)
Bacteriophage Market Recent Developments
- In February 2023, Micreos, a Swiss company, announced the expansion of its production capacity for phage therapy products. The expansion will meet the growing demand for these products from clinical trials and commercialization.
- In March 2023, Intralytix, a US company, announced the launch of its new phage therapy product for the treatment of E. coli infections. The product, called Intabilize, is a cocktail of bacteriophages that have been shown to be effective against E. coli in clinical trials.
- In April 2023, Proteon Pharmaceuticals, a US company, announced the completion of a Phase 2 clinical trial of its phage therapy product for the treatment of Clostridioides difficile infections. The product, called PRX-002, is a cocktail of bacteriophages that have been shown to be effective against Clostridioides difficile in clinical trials.
- In May 2023, NPO Microgen, a Russian company, announced the launch of its new phage therapy product for the treatment of Pseudomonas aeruginosa infections. The product, called ViroPhage, is a cocktail of bacteriophages that have been shown to be effective against Pseudomonas aeruginosa in clinical trials.
Bacteriophage Key Market Trends
- Rising Interest in Phage Therapy: There is a growing interest in the use of bacteriophages (viruses that infect and kill bacteria) for therapeutic purposes, known as phage therapy. As antibiotic resistance becomes a critical global health concern, researchers and healthcare professionals are exploring alternative treatments. Bacteriophages have shown potential in targeting specific bacterial infections, especially those resistant to antibiotics. The increasing understanding of phage biology, advances in phage isolation and production, and successful case studies are driving the exploration of phage therapy as a viable medical intervention.
- Integration of Bacteriophages in Agriculture: Bacteriophages are also gaining attention in agricultural practices. With a growing demand for sustainable and eco-friendly farming methods, bacteriophages are being investigated for their potential to control bacterial diseases in crops and livestock. They offer a targeted and precise approach to combat bacterial infections in agriculture, reducing the need for chemical pesticides and antibiotics. Researchers are developing phage-based biopesticides and feed additives to prevent bacterial outbreaks in crops and animals, aligning with the trend towards sustainable agriculture and reduced chemical usage.
Bacteriophage Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Component types team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global bacteriophage market analysis, the market is gaining momentum as a promising alternative to combat antibiotic-resistant bacterial infections. Bacteriophages are viruses that selectively infect and kill specific bacterial strains, offering a targeted and potentially more effective approach to treating infections. The rising global concern over antibiotic resistance, coupled with the need for novel therapeutic options, is driving market growth. Bacteriophages' ability to evolve and adapt to new strains of bacteria presents a dynamic solution in the fight against drug-resistant pathogens. However, challenges such as regulatory hurdles, limited clinical data, and manufacturing complexities need to be addressed. As research and clinical trials progress, and as the medical community seeks innovative treatments, the Bacteriophage Market is expected to expand. Continued investment in research, collaborations between academia and industry, and growing awareness of phage therapy's potential contribute to the market's optimistic outlook.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 39.81 million |
| Market size value in 2031 | USD 60.71 million |
| Growth Rate | 4.5% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Bacteriophage Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Bacteriophage Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Bacteriophage Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Bacteriophage Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Bacteriophage Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Bacteriophage Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
